🎉 Happy new year - taking stock of the #ATTRACT network 🇦🇹 🗺️ All participating sites across Austria, working together to enable equitable trial access. 🧠 Biobanking + 28-drug testing → functional precision oncology. 🔗 Learn more: tinyurl.com/2umu6auv #Glioblastoma #ClinicalTrials #NeuroOncology

🎄 Festive publication alert from ATTRACT 💫 Our new review in #CancerTreatmentReviews highlights how ex vivo drug screening can support #FunctionalPrecisionOncology and inform #ClinicalTrials like ATTRACT. doi.org/10.1016/j.ct... ✨ Wishing all a warm and restful holiday season - see you in 2026!

🏔️ Salzburg joins the #ATTRACT network - and the 1st tumor sample is already on the way! 🇦🇹 Expanding precision oncology access for #glioblastoma patients. 🧠 Biobanking + 28-drug testing → personalized insights. 👏 Thanks to the Salzburg team & @lbg.ac.at! #NeuroOncology #PrecisionMedicine #btsm

🚀 Another milestone for expanding nationwide access to precision care for #glioblastoma! 🇦🇹 The first patient included in our biobanking program at Klinik Donaustadt has been randomized 🎉 👏 Thanks to the local team, @lbg.ac.at & all partners. #NeuroOncology #ClinicalTrials #btsm

🧠 Bringing #PrecisionOncology to life! 🚀 At #EANO2025, Anna Sophie Berghoff presented the design of the #ATTRACT trial - testing 28 drugs on patient-derived tumor cells to personalize #glioblastoma therapy. 👏 Thanks to @lbg.ac.at & all partners in 🇦🇹! #NeuroOncology #ClinicalTrials #btsm

🎯 How can we make #PrecisionMedicine real for #glioblastoma? 🧠 The #ATTRACT trial tests 28 drugs on patient-derived cells & uses a molecular tumor board for #personalized therapy recommendation. 📚 Read our protocol paper in #NeuroOncology Advances: doi.org/10.1093/noaj... 📲 Follow us for updates!

🚀 #ATTRACT wächst! ⛔️ #KlinischeStudien sollten nicht nur auf wenige Zentren beschränkt sein. Deshalb erweitern wir unser #Biobanking, um Patient:innen mit #Glioblastom in ganz #Österreich 🇦🇹 Zugang zu ATTRACT zu ermöglichen. 🎉 Meilenstein: 1. Patient in Wiener Neustadt eingeschlossen!

🚀 #ATTRACT is growing! ⛔️ #ClinicalTrials shouldn’t be limited to a few centers. Therefore, we are expanding our #biobanking to give #glioblastoma patients across #Austria 🇦🇹 access to ATTRACT. 🎉 Milestone: 1st patient enrolled in Wiener Neustadt! #NeuroOncology #PrecisionMedicine #CancerResearch

🧠 What is #ATTRACT – and how could it improve #glioblastoma care? This video (🇩🇪 with 🇬🇧 subs) explains how we test 28 drugs on tumor cells & personalize therapy. Made by @lbg.ac.at w/ Anna Berghoff (ATTRACT Head), @mj-mair.bsky.social (Deputy Head) & Matthias Preusser (Mentor) 🚀 youtu.be/NfxxMZ_xmF4

🚀 We’re launching the BlueSky presence of #ATTRACT - a 🇦🇹 Clinical Research Group investigating ex-vivo drug screening 💊 for personalized #glioblastoma treatment, funded by @lbg.ac.at with @meduniwien.ac.at as lead institution. ➡️ Follow us for further insights! 🧠 #GlioblastomaAwarenessDay #NeuroOnc